Psychedelic-Assisted Psychotherapy

Psychedelic-Assisted Psychotherapy (PAT) #

Psychedelic-assisted psychotherapy (PAT) combines a therapeutic-dose empathogen with counseling to support more rapid emotional processing, parts work, and healing.

5-MAPB molecular structure

5-MAPB #

I recommend 5-MAPB (5-(N-methyl-2-aminopropyl)benzofuran), a legal, unscheduled empathogen with a pharmacological profile similar to MDMA.1 Like MDMA, 5-MAPB promotes feelings of emotional openness, empathy, and reduced fear creating a window in which difficult material becomes more accessible.

You can source 5-MAPB from Advanced Myco (PLÜR Beyond Molly Heart Tabs), an American supplier that publishes third-party Certificates of Analysis (COAs). See the manufacturer’s product page for the latest COA; a sample COA from January 2026 is available here.

How a Session Works #

A PAT session typically unfolds in three phases:

  1. Preparation — We meet beforehand (standard counseling session) to set intentions, review your history, and address any concerns.
  2. Medicine session — You self-administer your chosen dose. The experience lasts 4–6 hours. I hold space via video conferencing while you remain safely in your own home. Doses in PLÜR tablets:
    • 3 tablets (~75 mg) — Light
    • 4 tablets (~100 mg) — Moderate
    • 5 tablets (~125 mg) — Standard
  3. Integration — We resume regular counseling sessions.

To allow adequate neurological recovery, medicine sessions are spaced at least 3 months apart.2

Contraindications #

I am not a doctor and cannot provide medical advice. Please review the manufacturer’s product page for safety information and consult your physician before proceeding: Advanced Myco — PLÜR Beyond Molly.

5-MAPB is not scheduled under the US Controlled Substances Act as of April 2026. It is sourced domestically. You are responsible for understanding applicable law in your own jurisdiction.

Cost #

I charge my usual hourly rate. Most PAT programs charge $1,000–$3,000 or more per session; at my standard rate, this is among the most affordable PAT options available. You can schedule 4–5 consecutive hours to span the duration of the effects.

Notes #

  1. Under the Federal Analogue Act, a substance may be treated as a Schedule I controlled substance if it is “substantially similar” to a scheduled substance and intended for human consumption. Because no scientific standard defines what “substantially similar” means, this similarity cannot be quantified. 5-MAPB is unscheduled and legal. Comparison with MDMA is offered for informational purposes only. ↩︎

  2. Frequent or high-dose empathogen use is associated with cumulative serotonergic stress. A 3-month minimum interval is consistent with risk-reduction guidance derived from research on MDMA neurotoxicity (Parrott, A.C. [2013]. “MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users.” Neuroscience & Biobehavioral Reviews, 37[8], 1466–1484). ↩︎

April 29, 2026